TENAX THERAPEUTICS, INC.·4

Aug 7, 10:15 AM ET

Jebsen Michael B 4

4 · TENAX THERAPEUTICS, INC. · Filed Aug 7, 2018

Insider Transaction Report

Form 4
Period: 2018-08-07
Jebsen Michael B
Chief Financial Officer
Transactions
  • Disposition to Issuer

    common stock

    2018-07-31$6.25/sh+5,720$35,75034,680 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT